|
Jul 26
|
AbbVie's Immunology Products Continue to Deliver, Morgan Stanley Says
|
|
Jul 26
|
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
|
|
Jul 26
|
Two biotechs cut staff; AbbVie weathers biosimilar threat
|
|
Jul 26
|
AbbVie’s Q2 2024 net earnings drop to $1.37bn
|
|
Jul 26
|
Company News for Jul 26, 2024
|
|
Jul 26
|
Q2 2024 AbbVie Inc Earnings Call
|
|
Jul 26
|
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
|
|
Jul 25
|
Why AbbVie Stock Was Cruising Higher on Thursday
|
|
Jul 25
|
AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing
|
|
Jul 25
|
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
|
|
Jul 25
|
AbbVie Stock Hits Record High on Demand for Non-Humira Portfolio
|
|
Jul 25
|
AbbVie Stock Rises on Strong Sales of Immunology Drugs Other Than Humira
|
|
Jul 25
|
AbbVie stock gets lift after beating Q2 earnings estimates
|
|
Jul 25
|
Top Midday Stories: US Advance Q2 GDP Rises; Initial Jobless Claims Drop; Ford Earnings Fall; TotalEnergies' Lower Results; AbbVie Raises Guidance; IBM, ServiceNow Report Higher Results
|
|
Jul 25
|
New Drug Sales Lift AbbVie Stock
|
|
Jul 25
|
AbbVie (ABBV) Beats on Q2 Earnings & Sales, Ups '24 EPS View
|
|
Jul 11
|
AbbVie (ABBV) Gains As Market Dips: What You Should Know
|
|
Jul 11
|
AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock?
|
|
Jul 11
|
Dividend Investors: Don't Be Too Quick To Buy AbbVie Inc. (NYSE:ABBV) For Its Upcoming Dividend
|
|
Jul 11
|
The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
|